Solara Active Pharma Sciences Limited
NSE: SOLARA BSE: SOLARA
NSE
461.35
-0.85 (-0.18%)
Prev Close
462.2
Open Price
452
Volume
50,837
Today Low / High
450.65 / 463.6
52 WK Low / High
440.2 / 734.4
Range
438 - 484
BSE
462.40
1.30 (0.28%)
Prev Close
461.1
Open Price
440.4
Volume
1,526
Today Low / High
440.4 / 463.75
52 WK Low / High
440.4 / 734.2
Range
439 - 486
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 461.35 (target range: 438 - 484), reflecting a change of -0.85 (-0.1839%). On the BSE, it is listed at 462.4 (target range: 439 - 486), showing a change of 1.3 (0.28193%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
02 Mar
452.00
2.07%
27 Feb
463.10
-0.19%
26 Feb
472.60
-2.02%
25 Feb
476.00
-0.69%
24 Feb
472.30
0.18%
23 Feb
471.50
0.17%
20 Feb
475.00
-0.74%
19 Feb
480.00
-0.33%
18 Feb
483.90
-1.18%
17 Feb
482.05
0.34%
16 Feb
498.10
-2.26%
13 Feb
480.05
4.07%
12 Feb
487.90
-1.61%
11 Feb
490.10
-0.45%
10 Feb
479.95
2.15%
Solara Active Pharma Sciences Limited Graph
Solara Active Pharma Sciences Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Solara Active Pharma Sciences Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 461.35, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 462.40 | 467.02 | 420.32 - 513.73 |
| 471.65 | 377.32 - 565.98 | ||
| 476.27 | 333.39 - 619.15 | ||
| Bearish Scenario | 462.40 | 457.78 | 412.00 - 503.55 |
| 453.15 | 362.52 - 543.78 | ||
| 448.53 | 313.97 - 583.09 |
Overview of Solara Active Pharma Sciences Limited
ISIN
INE624Z01016
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
158,121
Market Cap
22,223,275,635
Last Dividend
0
Official Website
IPO Date
2018-06-27
DCF Diff
-94.59
DCF
567
Financial Ratios Every Investor Needs
Stock Dividend of SOLARA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2021-08-18 | August 18, 21 | 3 | 3 | 2021-08-20 | 2021-09-24 | |
| 2020-11-19 | November 19, 20 | 4 | 4 | 2020-11-20 | 2020-12-11 | |
| 2020-07-28 | July 28, 20 | 2 | 2 | 2020-07-29 | 2020-09-03 | 2020-05-07 |
| 2019-08-06 | August 06, 19 | 5 | 5 | 2019-08-07 | 2019-09-13 | 2019-05-16 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,283.76 Cr | 626.41 Cr | 657.35 Cr | 0.5121 | 34.48 Cr | 214.36 Cr | 445.66 Cr | 0.54 Cr | 0.14 | 206.28 Cr | 0.0004 |
| 2024-03-31 | 1,288.92 Cr | 1,403.98 Cr | -129.88 Cr | -0.1008 | 55.98 Cr | 24.33 Cr | -385.29 Cr | -567.39 Cr | -145.27 | -282.19 Cr | -0.4402 |
| 2023-03-31 | 1,426.61 Cr | 1,301.83 Cr | 124.78 Cr | 0.0875 | 46.16 Cr | 229.92 Cr | 8.56 Cr | -22.17 Cr | -6.16 | 152.36 Cr | -0.0155 |
| 2022-03-31 | 1,268.34 Cr | 707.89 Cr | 560.45 Cr | 0.4419 | 65.62 Cr | 238.83 Cr | -33.28 Cr | -58.15 Cr | -16.18 | 79.33 Cr | -0.0458 |
| 2021-03-31 | 1,596.80 Cr | 1,215.62 Cr | 381.18 Cr | 0.2387 | 52.91 Cr | 32.85 Cr | 261.80 Cr | 221.40 Cr | 63.59 | 413.85 Cr | 0.1387 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.11 Cr | 2,231.84 Cr | 1,134.93 Cr | 1,094.2400 Cr | 796.08 Cr | 791.97 Cr | 317.90 Cr | 1,076.47 Cr | 0.00 Cr | 0.00 Cr | 1.70 Cr | 944.1100 Cr |
| 2024-03-31 | 8.44 Cr | 2,350.96 Cr | 1,414.38 Cr | 933.9100 Cr | 1,011.50 Cr | 1,003.06 Cr | 359.70 Cr | 1,114.22 Cr | 4.19 Cr | 0.00 Cr | 1.70 Cr | 1,242.8500 Cr |
| 2023-03-31 | 8.73 Cr | 2,899.06 Cr | 1,396.60 Cr | 1,500.2200 Cr | 1,012.85 Cr | 1,004.12 Cr | 558.09 Cr | 1,159.05 Cr | 16.01 Cr | -83.31 Cr | 1.70 Cr | 1,100.9000 Cr |
| 2022-03-31 | 46.38 Cr | 2,952.53 Cr | 1,417.78 Cr | 1,524.8700 Cr | 1,037.37 Cr | 990.99 Cr | 575.55 Cr | 1,160.12 Cr | 38.40 Cr | 23.13 Cr | 0.42 Cr | 1,063.4200 Cr |
| 2021-03-31 | 197.69 Cr | 2,613.58 Cr | 1,020.82 Cr | 1,588.5200 Cr | 620.73 Cr | 423.04 Cr | 294.97 Cr | 1,038.86 Cr | 20.29 Cr | 28.49 Cr | -28.20 Cr | 788.7500 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 212.8200 Cr | -36.8300 Cr | -180.4800 Cr | 172.8800 Cr | -4.4900 Cr | 3.9500 Cr | -39.9400 Cr | 0.5400 Cr | -221.3800 Cr | 0.0000 Cr | 41.8000 Cr |
| 2024-03-31 | 108.8700 Cr | -3.5100 Cr | -105.6500 Cr | 67.8100 Cr | -0.2900 Cr | 8.4400 Cr | -41.0600 Cr | -488.4200 Cr | -2.1400 Cr | 0.0000 Cr | 13.0800 Cr |
| 2023-03-31 | 156.2500 Cr | -81.1400 Cr | -112.7600 Cr | 44.9400 Cr | -37.6500 Cr | 8.7300 Cr | -111.3100 Cr | -44.8100 Cr | -22.8800 Cr | 0.0000 Cr | 17.3200 Cr |
| 2022-03-31 | -242.0300 Cr | -242.8500 Cr | 333.5700 Cr | -450.6500 Cr | -151.3100 Cr | 46.3800 Cr | -208.6200 Cr | -91.1000 Cr | 417.3100 Cr | -10.7800 Cr | -280.5800 Cr |
| 2021-03-31 | 155.4600 Cr | -106.3000 Cr | 92.4900 Cr | -19.0200 Cr | 141.6500 Cr | 197.6900 Cr | -174.4800 Cr | 221.5000 Cr | -100.1500 Cr | -19.7300 Cr | -15.2400 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 349.00 Cr | 267.40 Cr | 81.60 Cr | 0.2338 | 11.77 Cr | -17.43 Cr | -3.92 | 30.59 Cr | -0.0499 |
| 2025-09-30 | 313.54 Cr | 154.00 Cr | 159.54 Cr | 0.5088 | 10.24 Cr | -10.10 Cr | -2.36 | 35.22 Cr | -0.0322 |
| 2025-06-30 | 319.15 Cr | 146.47 Cr | 172.68 Cr | 0.5411 | 33.44 Cr | 10.52 Cr | 2.46 | 58.00 Cr | 0.0330 |
| 2025-03-31 | 273.01 Cr | 118.09 Cr | 154.92 Cr | 0.5675 | 21.07 Cr | -2.10 Cr | -0.54 | 51.32 Cr | -0.0077 |
| 2024-12-31 | 300.31 Cr | 134.86 Cr | 165.45 Cr | 0.5509 | 33.14 Cr | 8.09 Cr | 2.03 | 59.17 Cr | 0.0269 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 3.71 Cr | 13.22 Cr | 16.93 Cr | 342.28 Cr | 368.70 Cr | 797.65 Cr | 1,070.61 Cr | 2,293.43 Cr | 1,035.97 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 4.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,096.91 Cr |
| 2025-03-31 | 4.11 Cr | 0.00 Cr | 4.11 Cr | 326.59 Cr | 317.90 Cr | 728.73 Cr | 1,076.47 Cr | 2,231.84 Cr | 1,134.93 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 6.07 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,088.69 Cr |
| 2024-09-30 | 6.07 Cr | 0.00 Cr | 6.07 Cr | 383.91 Cr | 289.71 Cr | 759.38 Cr | 1,099.18 Cr | 2,289.78 Cr | 1,201.09 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 10.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | -2.10 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 8.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 8.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -13.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2024-05-15 | May 15, 24 | 217:200 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,752.50 | ₹4,204,834,534,925.00 | ₹3,919,016.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,403.50 | ₹1,699,928,052,030.00 | ₹300,339.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,369.20 | ₹1,478,735,816,448.00 | ₹231,761.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,294.40 | ₹1,077,692,658,712.00 | ₹1,052,141.00 |
| Lupin Limited | LUPIN | ₹2,311.10 | ₹1,056,272,077,300.00 | ₹580,904.00 |
| Mankind Pharma Limited | MANKIND | ₹2,245.50 | ₹926,953,789,176.00 | ₹545,012.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹906.90 | ₹912,553,605,531.00 | ₹518,610.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,210.40 | ₹703,002,284,479.00 | ₹888,443.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,566.00 | ₹665,498,790,000.00 | ₹54,260.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,123.30 | ₹599,196,977,750.00 | ₹315,603.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,065.00 | ₹574,947,259,830.00 | ₹2,261,423.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,513.00 | ₹383,854,481,834.00 | ₹115,864.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,967.80 | ₹370,783,944,907.00 | ₹82,523.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,077.40 | ₹333,479,924,060.00 | ₹259,727.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,445.30 | ₹273,989,192,062.00 | ₹128,185.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,801.00 | ₹220,025,000,000.00 | ₹7,555.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,310.00 | ₹212,864,741,390.00 | ₹350,318.00 |
| Eris Lifesciences Limited | ERIS | ₹1,360.40 | ₹185,309,458,516.00 | ₹144,678.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹956.25 | ₹171,273,813,188.00 | ₹1,073,075.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,096.00 | ₹168,020,226,344.00 | ₹39,142.00 |
| Granules India Limited | GRANULES | ₹574.40 | ₹139,388,910,470.00 | ₹468,097.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹705.25 | ₹138,626,143,201.00 | ₹58,524.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹850.35 | ₹134,669,715,212.00 | ₹109,605.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,672.90 | ₹127,159,966,238.00 | ₹90,254.00 |
| Cohance Lifesciences Limited | COHANCE | ₹303.20 | ₹115,994,356,848.00 | ₹708,355.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹914.35 | ₹112,223,661,600.00 | ₹57,229.00 |
| Viyash Scientific Limited | VIYASH | ₹199.94 | ₹87,214,939,466.00 | ₹1,642,591.00 |
| Procter & Gamble Health Limited | PGHL | ₹4,987.60 | ₹82,791,077,663.00 | ₹22,174.00 |
| Strides Pharma Science Limited | STAR | ₹842.45 | ₹77,650,902,909.00 | ₹213,842.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹474.45 | ₹72,639,271,418.00 | ₹129,501.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹705.75 | ₹63,974,324,918.00 | ₹179,889.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹323.55 | ₹63,280,496,567.00 | ₹233,105.00 |
| FDC Limited | FDC | ₹372.05 | ₹60,573,491,752.00 | ₹125,826.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹125.92 | ₹40,863,758,361.00 | ₹481,526.00 |
| Innova Captab Limited | INNOVACAP | ₹664.30 | ₹38,014,520,335.00 | ₹27,921.00 |
| Suven Life Sciences Limited | SUVEN | ₹141.99 | ₹32,934,838,780.00 | ₹224,892.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹357.30 | ₹32,610,771,000.00 | ₹127,791.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹296.10 | ₹32,264,614,967.00 | ₹76,769.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹600.10 | ₹30,436,534,911.00 | ₹94,277.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,805.80 | ₹29,866,153,287.00 | ₹7,962.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹278.55 | ₹27,933,692,046.00 | ₹45,963.00 |
Key Executives
Whole Time Director & COO
Mohan Muthunarayanan
Gender: male
Year Born: 1972
Chief Human Resources Officer
Mohanraj S
Gender: male
Year Born:
Chief Risk Officer
Rajesh Patro
Gender: male
Year Born:
Chief Quality Officer
V. Sundara Moorthy
Gender: male
Year Born:
Company Secretary & Compliance Officer
Pooja Jaya Kumar
Gender: female
Year Born:
Chief Scientific Officer
Hero Velladurai
Gender: Not Specified
Year Born:
Founder & Non-Executive Director
Arun Kumar Pillai
Gender: male
Year Born: 1961
General Manager of Accounts
Raghavan Venkatramani
Gender: male
Year Born:
CEO & MD
Sandeep Rao
Gender: male
Year Born: 1973
Chief Financial Officer & Chief Investor Relations Officer
Sarat Kumar
Gender: male
Year Born:
Chief Commercial Officer
Vishal Mathur
Gender: male
Year Born:
FAQs about Solara Active Pharma Sciences Limited
Who is the CEO of the company?
The CEO is Sandeep Shashikantha Rao.
What is the current market price of the stock?
The current price is ₹461.35.
What is the 52-week price range?
The range is ₹440.2-734.4.
What is the market capitalization of the company?
The market capitalization is ₹2,222.33 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -107.41.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Solara Active Pharma Sciences Limited (ISIN: INE624Z01016) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹2,222.33 crores and an average daily volume of 158,121 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.